EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1

Caroline Hermitte, Hortense de Calbiac, Gilles Moulay, Antoine Mérien, Jeanne Lainé, Hélène Polvèche, Michel Cailleret, Stéphane Vassilopoulos, Edor Kabashi, Denis Furling, Cécile Martinat, Morgan Gazzola iD

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.70112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Caroline Hermitte und 11 weiteren Autor:innen. Beteiligte Einrichtung: INSERM/UEPS UMR 861, Paris Saclay University, I-STEM, Corbeil-Essonnes, France. Hauptthemen laut MEDLINE: Myotonic Dystrophy, Neuromuscular Junction, Alternative Splicing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Laboratoire d'Excellence Revive (Investissement d'Avenir), Agence Nationale de la Recherche (ANR), Region Ile-de-France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myotonic dystrophy type 1 (DM1) is a multisystemic neuromuscular disorder characterized by CTG repeat expansion in the 3′ untranslated region of the dystrophia myotonica protein kinase coding gene. The presence of expanded CTG repeats in DMPK mRNAs leads to the sequestration of RNA‐binding factors such as the Muscleblind‐like (MBNL) proteins, resulting in widespread splicing defects that contribute to progressive muscle weakness and myotonia. Previously, we identified misregulation of SORBS1 exon 25 splicing in both DM1 and MBNL1/2 double‐knockout human‐induced pluripotent stem cells (hiPSC)‐derived skeletal muscle cells, suggesting a potential role in DM1 physiopathology.

Methods

We investigated SORBS1 exon 25 splicing misregulation in human skeletal muscle biopsies from DM1 patients and healthy controls. The functional consequence of SORBS1 exon 25 exclusion was assessed in mice, zebrafish and hiPSC‐derived skeletal muscle cells using an antisense oligonucleotide‐mediated exon‐skipping strategy.

Results

In human congenital DM1 fetal skeletal muscle biopsies, SORBS1 exon 25 inclusion was reduced by 52.6 ± 10% compared to controls ( p < 0.001 ). Analysis of RNA sequencing data from the DMseq database further revealed significant misregulation in tibialis anterior biopsies from 40 adult DM1 patients, with a 15.8 ± 3.7% decrease in splice inclusion ( p < 0.0001 ). In mice, forced exclusion of Sorbs1 exon 25 led to neuromuscular junction degeneration, with increased denervation (10.5% ± 3.4%, p < 0.01 ) and postsynaptic destabilization (5.7% ± 2.5%, p < 0.05 ). In zebrafish, sorbs1 exon 25 misregulation significantly impaired locomotion, reducing trajectory, distance (57.9% ± 12%, p < 0.0001 ) and velocity (14% ± 0.5%, p < 0.05 ), while also disrupting acetylcholine receptor cluster morphology. Similarly, forced SORBS1 exon 25 exclusion in hiPSC‐derived skeletal muscle cells diminished the formation of large acetylcholine receptor clusters upon agrin stimulation by 34% ± 4.5% ( p < 0.0001 ).

Conclusion

Our study identifies SORBS1 alternative splicing as an essential MBNL‐regulated event during skeletal muscle development, potentially involved in neuromuscular junction formation and maintenance. The aberrant splicing of SORBS1 exon 25 in DM1 expands our understanding of how splicing dysregulation compromises neuromuscular system communication, shedding light on the broader impact of mRNA splicing regulation on NMJ integrity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myotonic DystrophyNeuromuscular JunctionAlternative SplicingHumansAnimalsMiceMuscle, SkeletalFemaleZebrafishMaleAdultExonsMiddle Aged

Stichwörter der Autor:innen

alternative splicingmyotonic dystrophy type 1neuromuscular junction

Autor:innen und Institutionen

  • INSERM/UEPS UMR 861, Paris Saclay University, I-STEM, Corbeil-Essonnes, France.
  • Laboratory of Translational Research for Neurological Disorders, Imagine Institute, Université de Paris, INSERM UMR 1163, Paris, France.
  • Centre de Recherche en Myologie, Sorbonne Université, INSERM, Institut de Myologie, Paris, France.
  • CECS/AFM, I-STEM, Corbeil-Essonnes, France.

ORCID-Profile: Morgan Gazzola

Förderung

  • Laboratoire d'Excellence Revive (Investissement d'Avenir)
  • Agence Nationale de la Recherche (ANR)
  • Region Ile-de-France
  • Association Française contre les Myopathies (AFM-Téléthon)

Zitieren

APA

Hermitte, C., de Calbiac, H., Moulay, G., Mérien, A., Lainé, J., Polvèche, H., Cailleret, M., Vassilopoulos, S., Kabashi, E., Furling, D., Martinat, C., & Gazzola, M. (2025). Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70112

Vancouver

Hermitte C, de Calbiac H, Moulay G, Mérien A, Lainé J, Polvèche H, et al. Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.70112

BibTeX
@article{Hermitte2025,
  author = {Hermitte, Caroline and de Calbiac, Hortense and Moulay, Gilles and Mérien, Antoine and Lainé, Jeanne and Polvèche, Hélène and Cailleret, Michel and Vassilopoulos, Stéphane and Kabashi, Edor and Furling, Denis and Martinat, Cécile and Gazzola, Morgan},
  title = {Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.70112}
}
Kostenlos starten →